Similarly in p53-mutant NSCLC cell lines, miR-125b was found to downregulate IGFBP-3 leading to a more invasive phenotype, associated with increased PI3K/AKT signaling [55]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.